0 results available. Select is focused ,type to refine list, press Down to open the menu,
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso...
The following section summarizes insights on AstraZeneca PLC's Net Income to Company:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Company in the financials category include:
This item represents the net income available to all stakeholders of the company and is presented as total income or loss before discontinued operatio...
AstraZeneca reported net income to company of 6.389 B for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes AstraZeneca’s Net Income to Company and common size over the last five years:
| Fiscal Year | Net Income to Company | Revenue | % Revenue |
|---|---|---|---|
| 2020-12-31 | 2.783 B | 23.564 B | 11.8% |
| 2021-12-31 | 104.9 M | 34.136 B | 0.3% |
| 2022-12-31 | 3.045 B | 41.006 B | 7.4% |
| 2023-12-31 | 5.014 B | 38.531 B | 13.0% |
| 2024-12-31 | 6.389 B | 49.065 B | 13.0% |
The tables below summarizes AstraZeneca’s Net Income to Company and common size over the last four quarters:
| Quarter Ending | Net Income to Company | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | 1.966 B | 11.435 B | 17.2% |
| 2024-06-30 | 1.732 B | 11.623 B | 14.9% |
| 2024-09-30 | 1.213 B | 11.48 B | 10.6% |
| 2024-12-31 | 1.361 B | 13.512 B | 10.1% |
The chart above depicts the distribution of net income to company for companies operating in the Healthcare sector in the Developed economic region. Over 2,500 companies were considered in this analysis, and 2,406 had meaningful values. The average net income to company of companies in the sector is -87.834 K with a standard deviation of 134 M.
AstraZeneca PLC's Net Income to Company of 6.389 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,506 |
| Included Constituents | 2,406 |
| Min | -328.3 M |
| Max | 1.174 B |
| Median | -4.593 M |
| Mean | -87.834 K |
| Standard Deviation | 134 M |
You can find companies with similar net income to company using this stock screener.